Search research articles
Contact Us
Filters
Showing results (1-10 of 163) with videos related to
Page
of 17
Sort By:
Molecular Pharmacology
|
March 1, 1973
Mechanism of inactivation of rabbit muscle glyceraldehyde 3-phosphate dehydrogenase by ethacrynic acid
D J Birkett
Agents and Actions. Supplements
|
January 1, 1985
The importance of unbound drug
D J Birkett
Clinical and Experimental Pharmacology & Physiology
|
June 1, 1989
Racemates or enantiomers: regulatory approaches
D J Birkett
Australian Family Physician
|
March 1, 1980
The practical application of drug assays in general practice
D J Birkett
British Journal of Clinical Pharmacology
|
October 1, 1995
Modelling the market uptake of new drugs following listing for subsidy in Australia. A report from the Drug Utilisation Subcommittee of the Australian Pharmaceutical Benefits Advisory Committee
D J Birkett, P McManus
Biochimica Et Biophysica Acta
|
December 20, 1982
The effects of N-B transition of human serum albumin on the specific drug-binding sites
S Wanwimolruk, D J Birkett
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
September 6, 1976
The interactions between iophenoxic acid, iopanoic acid, bilirubin and human serum albumin as studied by fluorescence and Sephadex gel filtration
D J Birkett, J Kapitulnik
Pharmacogenetics
|
February 1, 1993
The misuse of urinary metabolite excretion data in drug metabolism studies
J O Miners, D J Birkett
British Journal of Clinical Pharmacology
|
July 15, 1998
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
J O Miners, D J Birkett
The Medical Journal of Australia
|
July 23, 1983
A case for generic prescribing?
D J Birkett, R A Robson
Page
of 17
Search research articles
Search
Showing results (1-10 of 163) with videos related to
Sort By:
Page
of 17
Molecular Pharmacology
|
March 1, 1973
Mechanism of inactivation of rabbit muscle glyceraldehyde 3-phosphate dehydrogenase by ethacrynic acid
D J Birkett
Agents and Actions. Supplements
|
January 1, 1985
The importance of unbound drug
D J Birkett
Clinical and Experimental Pharmacology & Physiology
|
June 1, 1989
Racemates or enantiomers: regulatory approaches
D J Birkett
Australian Family Physician
|
March 1, 1980
The practical application of drug assays in general practice
D J Birkett
British Journal of Clinical Pharmacology
|
October 1, 1995
Modelling the market uptake of new drugs following listing for subsidy in Australia. A report from the Drug Utilisation Subcommittee of the Australian Pharmaceutical Benefits Advisory Committee
D J Birkett, P McManus
Biochimica Et Biophysica Acta
|
December 20, 1982
The effects of N-B transition of human serum albumin on the specific drug-binding sites
S Wanwimolruk, D J Birkett
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
September 6, 1976
The interactions between iophenoxic acid, iopanoic acid, bilirubin and human serum albumin as studied by fluorescence and Sephadex gel filtration
D J Birkett, J Kapitulnik
Pharmacogenetics
|
February 1, 1993
The misuse of urinary metabolite excretion data in drug metabolism studies
J O Miners, D J Birkett
British Journal of Clinical Pharmacology
|
July 15, 1998
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
J O Miners, D J Birkett
The Medical Journal of Australia
|
July 23, 1983
A case for generic prescribing?
D J Birkett, R A Robson
Page
of 17